A common type of diabetes medication may help cancer patients ward off the risk of heart failure by 50 per cent and boost long-term recovery, according to new research on Thursday. 

Heart failure is common among cancer patients, and can lead to a reduced quality of life, multiple admissions to hospital, or even death. It is caused both due to the deadly disease as well as because of chemotherapy -- the first line of cancer treatment.